The acute effect of calcium carbonate on the intestinal absorption of levothyroxine - PubMed

The acute effect of calcium carbonate on the intestinal absorption of levothyroxine

N Singh et al. Thyroid. 2001 Oct.

Abstract

To determine the acute effect of calcium, we measured levothyroxine absorption after ingestion of thyroxine (T4) with and without simultaneous ingestion of calcium (as calcium carbonate) in seven volunteers without thyroid disease. Serum total T4, total triiodothyronine (T3), free T4, and thyrotropin (TSH) levels were measured after ingestion of 1,000 microg of levothyroxine on two separate visits at 4-week intervals: (1) levothyroxine alone and (2) levothyroxine together with 2.0 g of calcium as calcium carbonate. The amount of absorbed levothyroxine was calculated as the incremental rise in serum T4 level during the first 6 hours multiplied by the volume of distribution for the hormone. When 1,000 microg of levothyroxine alone was given to subjects, the maximum average total T4 absorption was 837 microg (83.7% of the dose ingested) at 120 minutes. When levothyroxine was coadministered with 2.0 g of calcium (as calcium carbonate), the maximum average T4 absorption decreased to 579 microg (57.9% of the dose ingested) at 240 minutes. The total levothyroxine absorption over 6 hours was significantly greater with thyroxine than that with thyroxine and calcium (p = 0.02). The administration of calcium and levothyroxine in these subjects was associated with a significant reduction in the peak increment in serum total T4 (p = 0.02) and free T4 levels (p = 0.03), as well as a significant reduction in the overall increment in serum total T4 (p = 0.003), free T4 (p = 0.002), and total T3 levels (p = 0.01) over four time points (120 minutes, 240 minutes, 360 minutes, 1,440 minutes). In summary, this pharmacokinetic study in seven volunteers indicates that calcium carbonate acutely reduces T4 absorption.

Similar articles

• Effects of pharmacological fiber supplements on levothyroxine absorption.

  Chiu AC, Sherman SI. Chiu AC, et al. Thyroid. 1998 Aug;8(8):667-71. doi: 10.1089/thy.1998.8.667. Thyroid. 1998. PMID: 9737361

• Effect of calcium carbonate on the absorption of levothyroxine.

  Singh N, Singh PN, Hershman JM. Singh N, et al. JAMA. 2000 Jun 7;283(21):2822-5. doi: 10.1001/jama.283.21.2822. JAMA. 2000. PMID: 10838651

• The effect of famotidine, esomeprazole, and ezetimibe on levothyroxine absorption.

  Ananthakrishnan S, Braverman LE, Levin RM, Magnani B, Pearce EN. Ananthakrishnan S, et al. Thyroid. 2008 May;18(5):493-8. doi: 10.1089/thy.2007.0381. Thyroid. 2008. PMID: 18466075 Clinical Trial.

• Factors Affecting Gastrointestinal Absorption of Levothyroxine: A Review.

  Skelin M, Lucijanić T, Amidžić Klarić D, Rešić A, Bakula M, Liberati-Čizmek AM, Gharib H, Rahelić D. Skelin M, et al. Clin Ther. 2017 Feb;39(2):378-403. doi: 10.1016/j.clinthera.2017.01.005. Epub 2017 Jan 30. Clin Ther. 2017. PMID: 28153426 Review.

• Use of soy protein supplement and resultant need for increased dose of levothyroxine.

  Bell DS, Ovalle F. Bell DS, et al. Endocr Pract. 2001 May-Jun;7(3):193-4. doi: 10.4158/EP.7.3.193. Endocr Pract. 2001. PMID: 11421567 Review.

Cited by

• Phosphate binders as a cause of hypothyroidism in dialysis patients: practical indications from a review of the literature.

  Cataldo E, Columbano V, Nielsen L, Gendrot L, Covella B, Piccoli GB. Cataldo E, et al. BMC Nephrol. 2018 Jul 2;19(1):155. doi: 10.1186/s12882-018-0947-9. BMC Nephrol. 2018. PMID: 29966512 Free PMC article. Review.

• Levothyroxine replacement doses are affected by gender and weight, but not age.

  Devdhar M, Drooger R, Pehlivanova M, Singh G, Jonklaas J. Devdhar M, et al. Thyroid. 2011 Aug;21(8):821-7. doi: 10.1089/thy.2011.0029. Epub 2011 Jul 13. Thyroid. 2011. PMID: 21751885 Free PMC article.

• Levothyroxine absorption in morbidly obese patients before and after Roux-En-Y gastric bypass (RYGB) surgery.

  Rubio IG, Galrão AL, Santo MA, Zanini AC, Medeiros-Neto G. Rubio IG, et al. Obes Surg. 2012 Feb;22(2):253-8. doi: 10.1007/s11695-011-0452-8. Obes Surg. 2012. PMID: 21633823

• Levothyroxine liquid oral substitution as an alternative treatment for refractory hypothyroidism due to gastrointestinal malabsorption: A case report.

  Cherchir F, Oueslati I, Mouelhi Y, Talbi E, Feki M, Yazidi M, Chihaoui M. Cherchir F, et al. SAGE Open Med Case Rep. 2023 Nov 2;11:2050313X231209229. doi: 10.1177/2050313X231209229. eCollection 2023. SAGE Open Med Case Rep. 2023. PMID: 37927364 Free PMC article.

• Levothyroxine pseudo-malabsorption: testing and treatment in the outpatient setting.

  Rdzak GM, Whitman LM, Inzucchi SE. Rdzak GM, et al. Ther Adv Endocrinol Metab. 2018 Jul;9(7):217-222. doi: 10.1177/2042018818771433. Epub 2018 Apr 28. Ther Adv Endocrinol Metab. 2018. PMID: 29977500 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon